Loading...
NYSE: WST
West Pharmaceutical Services, Inc.
Healthcare · Medical - Instruments & Supplies
●S&P 500 since 2020
Market Cap
$17.21B
52w High
$322.34
52w Low
$187.43
P/E
35.00
Volume
841.00K
Outstanding Shares
72.02M
Company profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
CEOEric Green
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees10,600
IPO dateMar 17, 1980
Valuation
Forward P/E—
EV/EBITDA26.97
Enterprise value$19.52B
Stock splits
Sep 27, 20132:1
Sep 30, 20042:1
Jun 2, 19872:1
May 6, 19822:1
Profitability & growth
Revenue growth7.55%
Gross margin35.89%▲3.61%vs FY2024
Operating margin20.07%▼2.28%vs FY2024
ROE15.54%▼15.37%vs FY2024
Analyst consensus
RatingBuy
Target price$303.33▲26.92%
10
Buy
3
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 23, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.84
$1.51
Q3FY25
ActualEst.
$1.96
$1.68
Q4FY25
ActualEst.
$2.04
$1.83
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$766.2M
$726.09M
Q3FY25
ActualEst.
$804.3M
$785.71M
Q4FY25
ActualEst.
$805M
$794.89M
Q1FY26
Next Est.
—